
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17428333
[patent_doc_number] => 20220056041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Modified Rhodamine Dye and use Thereof in Biological Assays
[patent_app_type] => utility
[patent_app_number] => 17/299706
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -143
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299706 | Modified rhodamine dye and use thereof in biological assays | Dec 19, 2019 | Issued |
Array
(
[id] => 17050774
[patent_doc_number] => 20210260208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/724164
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724164 | Tubulysins and protein-tubulysin conjugates | Dec 19, 2019 | Issued |
Array
(
[id] => 17520423
[patent_doc_number] => 20220106272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Deuterated Forms And Derivatives Of Volinanserin
[patent_app_type] => utility
[patent_app_number] => 17/416011
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416011 | Deuterated Forms And Derivatives Of Volinanserin | Dec 19, 2019 | Abandoned |
Array
(
[id] => 16090289
[patent_doc_number] => 20200199131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/720935
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 4079
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720935 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16189357
[patent_doc_number] => 20200230206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => PEANUT ORAL IMMUNOTHERAPY DOSING SCHEDULE FOR MISSED DOSES
[patent_app_type] => utility
[patent_app_number] => 16/721805
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721805 | Peanut oral immunotherapy dosing schedule for missed doses | Dec 18, 2019 | Issued |
Array
(
[id] => 16090289
[patent_doc_number] => 20200199131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/720935
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 4079
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720935 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16090289
[patent_doc_number] => 20200199131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/720935
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 4079
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720935 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16090289
[patent_doc_number] => 20200199131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/720935
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 4079
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720935 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 16090175
[patent_doc_number] => 20200199074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
[patent_app_type] => utility
[patent_app_number] => 16/719217
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719217 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Dec 17, 2019 | Issued |
Array
(
[id] => 17162920
[patent_doc_number] => 11149007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
[patent_app_type] => utility
[patent_app_number] => 16/719171
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72100
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719171 | Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith | Dec 17, 2019 | Issued |
Array
(
[id] => 17330047
[patent_doc_number] => 11220500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Crystalline form of Valbenazine dibesylate
[patent_app_type] => utility
[patent_app_number] => 16/718841
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5145
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16718841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/718841 | Crystalline form of Valbenazine dibesylate | Dec 17, 2019 | Issued |
Array
(
[id] => 16072041
[patent_doc_number] => 20200190007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS FOR USE IN TREATING AUTOPHAGY-ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/717728
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717728 | Compounds, compositions, and methods for use in treating autophagy-associated disorders | Dec 16, 2019 | Issued |
Array
(
[id] => 18116319
[patent_doc_number] => 11547691
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-01-10
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/715447
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16669
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715447 | None | Dec 15, 2019 | Issued |
Array
(
[id] => 18427661
[patent_doc_number] => 11672862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Oral products with reduced irritation
[patent_app_type] => utility
[patent_app_number] => 16/707583
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14163
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707583 | Oral products with reduced irritation | Dec 8, 2019 | Issued |
Array
(
[id] => 16436994
[patent_doc_number] => 20200354320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/706296
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/706296 | PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS | Dec 5, 2019 | Abandoned |
Array
(
[id] => 17369840
[patent_doc_number] => 20220024892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => PROCESS FOR PREPARATION OF ANTHRANILAMIDES
[patent_app_type] => utility
[patent_app_number] => 17/311467
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311467 | Process for preparation of Anthranilamides | Dec 5, 2019 | Issued |
Array
(
[id] => 19325952
[patent_doc_number] => 12043617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => 4-(N-methyl) aminopiperidine myricetin derivative containing dithiocarbamate, preparation method and application
[patent_app_type] => utility
[patent_app_number] => 17/043508
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8273
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043508
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043508 | 4-(N-methyl) aminopiperidine myricetin derivative containing dithiocarbamate, preparation method and application | Dec 4, 2019 | Issued |
Array
(
[id] => 17369881
[patent_doc_number] => 20220024933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => 7 (METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/311406
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311406
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311406 | 7 (methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives | Dec 3, 2019 | Issued |
Array
(
[id] => 16383132
[patent_doc_number] => 10807954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Method for preparing triacetone amine
[patent_app_type] => utility
[patent_app_number] => 16/702667
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7891
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702667
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/702667 | Method for preparing triacetone amine | Dec 3, 2019 | Issued |
Array
(
[id] => 16680678
[patent_doc_number] => 10940134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Bicyclic compound and use thereof for medical purposes
[patent_app_type] => utility
[patent_app_number] => 16/698432
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 29097
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698432 | Bicyclic compound and use thereof for medical purposes | Nov 26, 2019 | Issued |